Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | IKK16 | 2.0 | uM | 4 | PDGF-BB | 22.5 | 66 | ||||
RA2159 | IL-17A | 100 | ng/mL | 4 | PDGF-BB | 26.0 | 62 | ||||
RA2159 | EO1428 | 1.0 | uM | IL-17A | 100 | ng/mL | 4 | PDGF-BB | 26.0 | 65 | |
RA2159 | PI103 | 0.1 | uM | IL-17A | 100 | ng/mL | 4 | PDGF-BB | 27.0 | 77 | |
RA2159 | Sigma A6730 | 3.0 | uM | IL-17A | 100 | ng/mL | 4 | PDGF-BB | 22.0 | 74 | |
RA2159 | JNK-IN-8 | 3.0 | uM | IL-17A | 100 | ng/mL | 4 | PDGF-BB | 23.0 | 66 | |
RA2159 | JNK-IN-11 | 0.3 | uM | IL-17A | 100 | ng/mL | 4 | PDGF-BB | 29.5 | 68 | |
RA2159 | Tofacitinib | 0.3 | uM | 4 | PDGF-BB | 22.5 | 84 | ||||
N2586 | IL-17A | 100 | ng/mL | 4 | PDGF-BB | 28.0 | 56 | ||||
N2586 | EO1428 | 1.0 | uM | IL-17A | 100 | ng/mL | 4 | PDGF-BB | 26.0 | 97 | |
N2586 | PI103 | 0.1 | uM | IL-17A | 100 | ng/mL | 4 | PDGF-BB | 26.0 | 61 | |
N2586 | Sigma A6730 | 3.0 | uM | IL-17A | 100 | ng/mL | 4 | PDGF-BB | 25.5 | 62 | |
N2586 | JNK-IN-8 | 3.0 | uM | IL-17A | 100 | ng/mL | 4 | PDGF-BB | 29.5 | 54 | |
N2586 | JNK-IN-11 | 0.3 | uM | IL-17A | 100 | ng/mL | 4 | PDGF-BB | 30.0 | 65 | |
N2586 | Tofacitinib | 0.3 | uM | 4 | PDGF-BB | 23.0 | 63 | ||||
RA2159 | IL-6 | 100 | ug/mL | 4 | PDGF-BB | 25.0 | 69 | ||||
RA2159 | EO1428 | 1.0 | uM | IL-6 | 100 | ug/mL | 4 | PDGF-BB | 24.0 | 63 | |
RA2159 | PI103 | 0.1 | uM | IL-6 | 100 | ug/mL | 4 | PDGF-BB | 23.5 | 50 | |
RA2159 | Sigma A6730 | 3.0 | uM | IL-6 | 100 | ug/mL | 4 | PDGF-BB | 24.0 | 43 | |
RA2159 | JNK-IN-8 | 3.0 | uM | IL-6 | 100 | ug/mL | 4 | PDGF-BB | 19.0 | 47 | |
RA2159 | JNK-IN-11 | 0.3 | uM | IL-6 | 100 | ug/mL | 4 | PDGF-BB | 22.5 | 72 | |
RA2159 | Ruxolitinib | 0.3 | uM | 4 | PDGF-BB | 24.0 | 45 | ||||
N2586 | IL-6 | 100 | ug/mL | 4 | PDGF-BB | 23.5 | 52 | ||||
N2586 | EO1428 | 1.0 | uM | IL-6 | 100 | ug/mL | 4 | PDGF-BB | 21.0 | 40 | |
N2586 | PI103 | 0.1 | uM | IL-6 | 100 | ug/mL | 4 | PDGF-BB | 23.0 | 71 |